Radiation Therapy Market Overview and Forecast by 2031
The Radiation Therapy Market is expected to register a CAGR of 13.2% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Product (External Beam Radiotherapy, Internal Beam Radiotherapy/Brachytherapy, and Systemic Radiotherapy). The report further presents analysis based on the Technology (Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, 3D Conformal Radiotherapy (3D CRT), Volumetric Modulated Arc Therapy (VMAT), and Others). The report is segmented by Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head And Neck Cancer, Colorectal Cancer, and Other Cancers). The report further presents analysis based on the End user (Hospitals and Independent Radiotherapy Centers). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Radiation Therapy Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Radiation Therapy Market Segmentation
Product- External Beam Radiotherapy
- Internal Beam Radiotherapy/Brachytherapy
- Systemic Radiotherapy
- Image-Guided Radiotherapy
- Intensity Modulated Radiotherapy
- Stereotactic Technology
- Proton Beam Therapy
- 3D Conformal Radiotherapy
- Volumetric Modulated Arc Therapy
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Head And Neck Cancer
- Colorectal Cancer
- Other Cancers
- Hospitals and Independent Radiotherapy Centers
- Hospitals and Independent Radiotherapy Centers
Strategic Insights
Radiation Therapy Market Growth Drivers- Increasing Prevalence of Cancer: Cancer is one of the common health conditions significantly impacting society worldwide. According to the World Health Organization (WHO), cancer is the leading cause of death worldwide, accounting for 9.7 million deaths and 20 million new cancer cases in 2022 and it is expected to reach ~35 million new cancer cases by 2050. Radiation therapy can be used at any point in the treatment and can be combined with other treatments such as surgery, chemotherapy, immunotherapy and others.
- Initiatives to Support Developments in Radiation Oncology: The governments and organizations are introducing missions and programs for the quick and effective treatment of cancer with the use of radiotherapy. In September 2023, the International Atomic Energy Agency (IAEA) announced the “Rays of Hope”-flagship cancer initiative for the development of radiotherapy infrastructure. In developed countries such as the US, Germany, UK, France, and others nearly all patients have access to radiotherapy.
- Increasing awareness and implements screening programs that affect the radiation oncology field. Screening programs for various cancers, including breast, cervical, and colorectal carcinomas, are being done more extensively now, with a resultant earlier diagnosis and initiation of treatment. Patients diagnosed at an earlier stage of cancer are more likely to be eligible for radiotherapy as a primary or adjuvant treatment, which improves outcomes.
- Technological Advancement in Radiation Oncology: Radiotherapy focuses on destroying the cancerous cells maximum sparing of healthy cells which was achieved over the period of time owing to the advancement in imaging technology such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET) and others. These imaging technologies helps in identifying the tumors cells along with its exact position and size which led to the development of 3D conformal radiotherapy.
- Combonation with Other Treatments: The use of radiotherapy in combination with other treatments enhances the effectiveness of the entire treatment regimen while also improving the outcome in the care of patients suffering from this deadly disease. In most cases, a multidisciplinary approach allows for better control of the disease while also preventing resistance to the treatment. Simultaneous administration of chemotherapy along with radiotherapy has enhanced the combined effects that are often beneficial for specific types of cancers like lung and cervical cancers. Integration with other treatments is a prominent approach in contemporary oncology.
- Integration with Robotics: The integration of robotic-assisted technologies combined with artificial intelligence into radiotherapy is revolutionizing cancer treatment. This further enhances precision, efficiency, and patient outcomes. The robotic systems most notably include the CyberKnife, which provides highly accurate radiation delivery to the tumor, sparing healthy tissues around it, and the Versa HD. Robots can then facilitate adaptive radiotherapy where the treatment plans can change according to the fluctuations in size or location of the tumor across the duration of the treatments.
- Strategic Initiatives in Radiation Oncology: Constant evolution in radiotherapy by the market players in terms of product development, innovation, product launch, product approval, merger, acquisition and partnerships, and others is expected to contribute the market growth. In May 2024, Elekta launched its latest linear accelerator (linac), Evo, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments.
- Use of Telemedicine: Improving accessibility, efficiency, and outcomes for patients, telemedicine and remote planning are revolutionizing the practice of radiotherapy. Telemedicine overcomes distance barriers and allows consultations directly between radiation oncologists and patients in rural or underserved areas without requiring travel. Remote planning streamlines the workflow further, allowing rapid adjustments and approvals to ultimately reduce diagnosis-to-treatment time. Remote access for imaging studies helps radiologists in reviewing scans and sending back feedback to radiation oncologists within the shortest period imaginable.
- Personalized Medicine: Personalized medicine in radiotherapy is based on individual characteristics, genetic, molecular, and clinical factors in the treatment of patients, optimizing radiation therapy at minimum toxic side effects. With more frequent imaging, the radiation delivery can be modified in accordance with a change in the tumor over time.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Radiation Therapy Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Radiation Therapy Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Players operating in the market are Varian Medical Systems, Elekta AB, Accuray Inc, Ion Beam Applications, BD, Perspective Therapeutics, Nordion, and Mevion Medical Systems
External Beam Radiation Therapy segment, by product, dominated the market in 2023.
North America region dominated the Ophthalmic Lasers market in 2023.
The Radiation Therapy Market is estimated to witness a CAGR of 13.2% from 2023 to 2031
The major factors driving the Radiation Therapy market are:
1. Increasing Prevalence of Cancer.
2.Initiatives to Support Developments in Radiation Oncology
Strategic initiative in radiation therapy act as a opportunity for growth of the market in forecast period.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Radiation Therapy Market- By Product
1.3.2. Radiation Therapy Market- By Application
1.3.3. Radiation Therapy Market- By End User
1.3.4. Radiation Therapy Market- By Region
1.3.4.1. By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RADIATION THERAPY MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis
5. RADIATION THERAPY MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. RADIATION THERAPY MARKET- GLOBAL ANALYSIS
6.1. RADIATION THERAPY MARKET - GLOBAL MARKET OVERVIEW
6.2. RADIATION THERAPY MARKET - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS
7. RADIATION THERAPY MARKET REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. EXTERNAL BEAM RADIOTHERAPY MARKET
7.3.1. Overview
7.3.2. External Beam Radiotherapy Market Forecast And Analysis (US$ Mn)
7.3.3. Linear Accelerators Market
7.3.3.1. Overview
7.3.3.2. Linear Accelerators Market Forecast and Analysis (US$ Mn)
7.3.4. Particle Therapy Systems Market
7.3.4.1. Overview
7.3.4.2. Particle Therapy Systems Market Forecast and Analysis (US$ Mn)
7.3.5. Conventional Cobalt-60 Teletherapy Units Market
7.3.5.1. Overview
7.3.5.2. Conventional Cobalt-60 Teletherapy Units Market Forecast and Analysis (US$ Mn)
7.4. INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET
7.4.1. Overview
7.4.2. Internal Beam Radiotherapy/Brachytherapy Market Forecast And Analysis (US$ Mn)
7.4.3. Seeds Market
7.4.3.1. Overview
7.4.3.2. Seeds Market Forecast and Analysis (US$ Mn)
7.4.4. Applicators Market
7.4.4.1. Overview
7.4.4.2. Applicators Market Forecast and Analysis (US$ Mn)
7.4.5. Afterloaders Market
7.4.5.1. Overview
7.4.5.2. Afterloaders Market Forecast and Analysis (US$ Mn)
7.4.6. Electronic Brachytherapy Products Market
7.4.6.1. Overview
7.4.6.2. Electronic Brachytherapy Products Market Forecast and Analysis (US$ Mn)
7.5. SYSTEMIC RADIOTHERAPY MARKET
7.5.1. Overview
7.5.2. Systemic Radiotherapy Market Forecast And Analysis (US$ Mn)
7.5.3. Iobenguane (I-131)Market
7.5.3.1. Overview
7.5.3.2. Iobenguane (I-131) Market Forecast and Analysis (US$ Mn)
7.5.4. Samarium-153 Market
7.5.4.1. Overview
7.5.4.2. Samarium-153 Market Forecast and Analysis (US$ Mn)
7.5.5. Rhenium-186 Market
7.5.5.1. Overview
7.5.5.2. Rhenium-186 Market Forecast and Analysis (US$ Mn)
7.5.6. Others Market
7.5.6.1. Overview
7.5.6.2. Others Market Forecast and Analysis (US$ Mn)
8. RADIATION THERAPY MARKET REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. IMAGE-GUIDED RADIOTHERAPY (IGRT) MARKET
8.3.1. Overview
8.3.2. Image-guided Radiotherapy (IGRT) Market Forecast and Analysis (US$ Mn)
8.4. INTENSITY MODULATED RADIOTHERAPY (IMRT) MARKET
8.4.1. Overview
8.4.2. Intensity Modulated Radiotherapy (IMRT) Market Forecast and Analysis (US$ Mn)
8.5. STEREOTACTIC TECHNOLOGY MARKET
8.5.1. Overview
8.5.2. Stereotactic Technology Market Forecast and Analysis (US$ Mn)
8.6. PROTON BEAM THERAPY MARKET
8.6.1. Overview
8.6.2. Proton Beam Therapy Market Forecast and Analysis (US$ Mn)
8.7. 3D CONFORMAL RADIOTHERAPY (3D CRT) MARKET
8.7.1. Overview
8.7.2. 3D Conformal Radiotherapy (3D CRT) Market Forecast and Analysis (US$ Mn)
8.8. VOLUMETRIC MODULATED ARC THERAPY (VMAT) MARKET
8.8.1. Overview
8.8.2. Volumetric Modulated Arc Therapy (VMAT) Market Forecast and Analysis (US$ Mn)
8.9. OTHERS MARKET
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis (US$ Mn)
9. RADIATION THERAPY MARKET REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. PROSTATE CANCER MARKET
9.3.1. Overview
9.3.2. Prostate Cancer Market Forecast and Analysis (US$ Mn)
9.4. BREAST CANCER MARKET
9.4.1. Overview
9.4.2. Breast Cancer Market Forecast and Analysis (US$ Mn)
9.5. LUNG CANCER MARKET
9.5.1. Overview
9.5.2. Lung Cancer Market Forecast and Analysis (US$ Mn)
9.6. HEAD AND NECK CANCER MARKET
9.6.1. Overview
9.6.2. Head and Neck Cancer Market Forecast and Analysis (US$ Mn)
9.7. COLORECTAL CANCER MARKET
9.7.1. Overview
9.7.2. Colorectal Cancer Market Forecast and Analysis (US$ Mn)
9.8. OTHER CANCERS MARKET
9.8.1. Overview
9.8.2. Other Cancers Market Forecast and Analysis (US$ Mn)
10. RADIATION THERAPY MARKET REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS MARKET
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis (US$ Mn)
10.4. INDEPENDENT RADIOTHERAPY CENTERS MARKET
10.4.1. Overview
10.4.2. Independent Radiotherapy Centers Market Forecast and Analysis (US$ Mn)
11. RADIATION THERAPY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA RADIATION THERAPY MARKET
11.1.1. North America Radiation Therapy Market Forecasts and Analysis (US$ Mn)
11.1.2. North America Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.1.2.1. North America External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.1.2.2. North America Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.1.2.3. North America Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.1.3. North America Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.1.4. North America Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.1.5. North America Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.1.6. North America Radiation Therapy Market Forecasts and Analysis - By Country
11.1.7. US Market Overview
11.1.7.1. US Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.1.7.1.1. US External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.1.7.1.2. US Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.1.7.1.3. US Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.1.7.2. US Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.1.7.3. US Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.1.7.4. US Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.1.8. Canada Market Overview
11.1.8.1. Canada Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.1.8.1.1. Canada External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.1.8.1.2. Canada Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.1.8.1.3. Canada Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.1.8.2. Canada Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.1.8.3. Canada Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.1.8.4. Canada Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.1.9. Mexico Market Overview
11.1.9.1. Mexico Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.1.9.1.1. Mexico External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.1.9.1.2. Mexico Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.1.9.1.3. Mexico Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.1.9.2. Mexico Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.1.9.3. Mexico Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.1.9.4. Mexico Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.2. EUROPE RADIATION THERAPY MARKET
11.2.1. Europe Radiation Therapy Market Forecasts and Analysis (US$ Mn)
11.2.2. Europe Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.2.2.1. Europe External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.2.2.2. Europe Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.2.2.3. Europe Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.2.3. Europe Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.2.4. Europe Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.5. Europe Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.2.6. Europe Radiation Therapy Market Forecasts and Analysis - By Country
11.2.7. UK Market Overview
11.2.7.1. UK Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.2.7.1.1. UK External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.2.7.1.2. UK Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.2.7.1.3. UK Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.2.7.2. UK Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.2.7.3. UK Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.7.4. UK Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.2.8. Germany Market Overview
11.2.8.1. Germany Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.2.8.1.1. Germany External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.2.8.1.2. Germany Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.2.8.1.3. Germany Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.2.8.2. Germany Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.2.8.3. Germany Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.8.4. Germany Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.2.9. France Market Overview
11.2.9.1. France Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.2.9.1.1. France External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.2.9.1.2. France Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.2.9.1.3. France Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.2.9.2. France Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.2.9.3. France Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.9.4. France Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.3. ASIA PACIFIC RADIATION THERAPY MARKET
11.3.1. Asia Pacific Radiation Therapy Market Forecasts and Analysis (US$ Mn)
11.3.2. Asia Pacific Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.3.2.1. Asia Pacific External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.3.2.2. Asia Pacific Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.3.2.3. Asia Pacific Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.3.3. Asia Pacific Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.3.4. Asia Pacific Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.5. Asia Pacific Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.3.6. Asia Pacific Radiation Therapy Market Forecasts and Analysis - By Country
11.3.7. Japan Market Overview
11.3.7.1. Japan Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.3.7.1.1. Japan External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.3.7.1.2. Japan Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.3.7.1.3. Japan Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.3.7.2. Japan Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.3.7.3. Japan Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.7.4. Japan Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.3.8. China Market Overview
11.3.8.1. China Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.3.8.1.1. China External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.3.8.1.2. China Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.3.8.1.3. China Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.3.8.2. China Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.3.8.3. China Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.8.4. China Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.3.9. India Market Overview
11.3.9.1. India Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.3.9.1.1. India External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.3.9.1.2. India Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.3.9.1.3. India Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.3.9.2. India Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.3.9.3. India Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.9.4. India Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.4. MIDDLE EAST & AFRICA (MEA) RADIATION THERAPY MARKET
11.4.1. Middle East & Africa (MEA) Radiation Therapy Market Forecasts and Analysis (US$ Mn)
11.4.2. Middle East & Africa (MEA) Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.4.2.1. Middle East & Africa (MEA) External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.4.2.2. Middle East & Africa (MEA) Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.4.2.3. Middle East & Africa (MEA) Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.4.3. Middle East & Africa (MEA) Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.4.4. Middle East & Africa (MEA) Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.4.5. Middle East & Africa (MEA) Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.4.6. Middle East & Africa (MEA) Radiation Therapy Market Forecasts and Analysis - By Country
11.4.7. South Africa Market Overview
11.4.7.1. South Africa Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.4.7.1.1. South Africa External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.4.7.1.2. South Africa Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.4.7.1.3. South Africa Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.4.7.2. South Africa Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.4.7.3. South Africa Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.4.7.4. South Africa Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.4.8. Saudi Arabia Market Overview
11.4.8.1. Saudi Arabia Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.4.8.1.1. Saudi Arabia External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.4.8.1.2. Saudi Arabia Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.4.8.1.3. Saudi Arabia Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.4.8.2. Saudi Arabia Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.4.8.3. Saudi Arabia Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.4.8.4. Saudi Arabia Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.4.9. UAE Market Overview
11.4.9.1. UAE Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.4.9.1.1. UAE External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.4.9.1.2. UAE Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.4.9.1.3. UAE Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.4.9.2. UAE Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.4.9.3. UAE Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.4.9.4. UAE Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.5. SOUTH AND CENTRAL AMERICA RADIATION THERAPY MARKET
11.5.1. South And Central America Radiation Therapy Market Forecasts and Analysis (US$ Mn)
11.5.2. South And Central America Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.5.2.1. South And Central America External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.5.2.2. South And Central America Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.5.2.3. South And Central America Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.5.3. South And Central America Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.5.4. South And Central America Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.5.5. South And Central America Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
11.5.6. South And Central America Radiation Therapy Market Forecasts and Analysis - By Country
11.5.7. Brazil Market Overview
11.5.7.1. Brazil Radiation Therapy Market Forecasts and Analysis - By Product (US$ Mn)
11.5.7.1.1. Brazil External Beam Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.5.7.1.2. Brazil Internal Beam Radiotherapy/Brachytherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.5.7.1.3. Brazil Systemic Radiotherapy Market Forecasts and Analysis - By Type (US$ Mn)
11.5.7.2. Brazil Radiation Therapy Market Forecasts and Analysis - By Application (US$ Mn)
11.5.7.3. Brazil Radiation Therapy Market Forecasts and Analysis - By Technology (US$ Mn)
11.5.7.4. Brazil Radiation Therapy Market Forecasts and Analysis - By End User (US$ Mn)
12. INDUSTRY LANDSCAPE
12.1. ORGANIC GROWTH STRATEGIES
12.1.1. New Product Launches
12.1.2. Marketing & Promotional Activities
12.2. INORGANIC GROWTH STRATEGIES
12.2.1. Partnerships, Collaborations, and Joint Ventures
12.2.2. Mergers & Acquisitions
13. RADIATION THERAPY MARKET, KEY COMPANY PROFILES
13.1. HITACHI, LTD.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. NORDION (CANADA) INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. MEVION MEDICAL SYSTEMS.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ISORAY INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BD
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. IBA WORLDWIDE
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ACCURAY INCORPORATED
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ELEKTA AB
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. VARIAN MEDICAL SYSTEMS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Hitachi, Ltd.;
2. Nordion (Canada) Inc.
3. Mevion Medical Systems.
4. Isoray Inc.
5. BD
6. IBA Worldwide
7. Accuray Incorporated
8. Elekta AB
9. Varian Medical Systems, Inc.
10. Panacea Medical Technologies Pvt. Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For